A detailed history of Twin Capital Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Twin Capital Management Inc holds 8,450 shares of BIIB stock, worth $1.24 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
8,450
Previous 8,518 0.8%
Holding current value
$1.24 Million
Previous $1.97 Million 17.07%
% of portfolio
0.19%
Previous 0.24%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$189.07 - $236.8 $12,856 - $16,102
-68 Reduced 0.8%
8,450 $1.64 Million
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $49,535 - $61,547
260 Added 3.15%
8,518 $1.97 Million
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $125,727 - $158,752
-593 Reduced 6.7%
8,258 $1.78 Million
Q4 2023

Jan 31, 2024

SELL
$222.59 - $267.94 $61,880 - $74,487
-278 Reduced 3.05%
8,851 $2.29 Million
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $135,262 - $152,665
-534 Reduced 5.53%
9,129 $2.35 Million
Q2 2023

Aug 07, 2023

SELL
$275.25 - $318.06 $98,814 - $114,183
-359 Reduced 3.58%
9,663 $2.75 Million
Q1 2023

May 08, 2023

SELL
$256.56 - $292.34 $399,720 - $455,465
-1,558 Reduced 13.45%
10,022 $2.79 Million
Q4 2022

Jan 31, 2023

BUY
$252.44 - $306.72 $461,965 - $561,297
1,830 Added 18.77%
11,580 $3.21 Million
Q3 2022

Oct 21, 2022

BUY
$194.69 - $268.46 $1.9 Million - $2.62 Million
9,750 New
9,750 $2.6 Million
Q4 2021

Feb 07, 2022

SELL
$223.92 - $287.77 $346,404 - $445,180
-1,547 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$282.99 - $369.05 $5,093 - $6,642
18 Added 1.18%
1,547 $438,000
Q1 2021

May 06, 2021

SELL
$242.95 - $284.63 $2.74 Million - $3.22 Million
-11,298 Reduced 88.08%
1,529 $428,000
Q4 2020

Feb 11, 2021

SELL
$236.26 - $355.63 $91,668 - $137,984
-388 Reduced 2.94%
12,827 $3.14 Million
Q3 2020

Nov 05, 2020

SELL
$264.77 - $305.71 $45,275 - $52,276
-171 Reduced 1.28%
13,215 $3.75 Million
Q2 2020

Aug 04, 2020

SELL
$258.66 - $342.55 $243,916 - $323,024
-943 Reduced 6.58%
13,386 $3.58 Million
Q1 2020

Apr 29, 2020

BUY
$268.85 - $341.04 $2,688 - $3,410
10 Added 0.07%
14,329 $4.53 Million
Q4 2019

Jan 29, 2020

SELL
$220.06 - $304.07 $484,132 - $668,954
-2,200 Reduced 13.32%
14,319 $4.25 Million
Q3 2019

Oct 28, 2019

SELL
$217.44 - $243.88 $241,358 - $270,706
-1,110 Reduced 6.3%
16,519 $3.85 Million
Q2 2019

Aug 01, 2019

SELL
$219.29 - $241.72 $2.27 Million - $2.5 Million
-10,335 Reduced 36.96%
17,629 $4.12 Million
Q1 2019

May 03, 2019

BUY
$216.71 - $338.96 $15,169 - $23,727
70 Added 0.25%
27,964 $6.61 Million
Q4 2018

Feb 04, 2019

SELL
$278.5 - $352.75 $422,206 - $534,769
-1,516 Reduced 5.15%
27,894 $8.39 Million
Q3 2018

Nov 08, 2018

BUY
$293.51 - $383.83 $666,267 - $871,294
2,270 Added 8.36%
29,410 $10.4 Million
Q2 2018

Aug 13, 2018

BUY
$257.52 - $306.91 $87,556 - $104,349
340 Added 1.27%
27,140 $7.88 Million
Q1 2018

May 01, 2018

SELL
$260.13 - $367.91 $1.96 Million - $2.77 Million
-7,522 Reduced 21.92%
26,800 $7.34 Million
Q4 2017

Jan 29, 2018

BUY
$307.64 - $344.58 $2.55 Million - $2.86 Million
8,302 Added 31.91%
34,322 $10.9 Million
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $728,178 - $853,897
2,590 Added 11.05%
26,020 $8.15 Million
Q2 2017

Aug 07, 2017

BUY
N/A
23,430
23,430 $6.36 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Twin Capital Management Inc Portfolio

Follow Twin Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.